Pyxis Oncology
Price & Volume
Stats
See more52W Range | $0.83-$5.38 |
Market Cap | $62.8M |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $16.1M |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $15.6M |
Diluted EPS | -$1.32 |
News
See moreYahoo Finance • 22 days ago
Pyxis Oncology to Participate in the Stifel 2025 Virtual Targeted Oncology Forum
Yahoo Finance • last month
Pyxis Oncology Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Yahoo Finance • 2 months ago
Pyxis Oncology Granted FDA Fast Track Designation for PYX-201 Monotherapy in Patients with Recurrent or Metastatic Head and Neck Cancer
Yahoo Finance • 3 months ago
Pyxis Oncology Initiates New PYX-201 Combination Trial and Initiates Cohort Expansions of Ongoing Monotherapy Trial
About
CEO | Dr. Lara S. Sullivan M.D., MBA |
CFO | Ms. Pamela Yanchik Connealy M.B.A. |
Address | 321 Harrison Avenue, Boston, MA, United States, 02118 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 44 |
